Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial.

• Үндсэн зохиолчид: Leonore Lovis (Зохиогч), Tippi K Mak (Зохиогч), Khampheng Phongluxa (Зохиогч), Phonepasong Ayé Soukhathammavong (Зохиогч), Youthanavanh Vonghachack (Зохиогч), Jennifer Keiser (Зохиогч), Penelope Vounatsou (Зохиогч), Marcel Tanner (Зохиогч), Christoph Hatz (Зохиогч), Jürg Utzinger (Зохиогч), Peter Odermatt (Зохиогч), Kongsap Akkhavong (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Public Library of Science (PLoS), 2012-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

BACKGROUND: Schistosomiasis and opisthorchiasis are of public health importance in Southeast Asia. Praziquantel (PZQ) is the drug of choice for morbidity control but few dose comparisons have been made. METHODOLOGY: Ninety-three schoolchildren were enrolled in an area of Lao PDR where Schistosoma me...